Fundraising Fox

Aethon Therapeutics

New York, US · Founded 2022 · Delaware corporation · 16 employees on LinkedIn

Biotech

Founders & leadership

WE
William EngelsNamed on SEC filing

Board

SH
Seth HarrisonBoard director
PD
Paul Da Silva JardineinBoard directorVenture Partner at Apple Tree Venture Management Llc
RC
Rajesh ChoprainBoard directorVenture Partner at Apple Tree Venture Management Llc

Reported raises · per SEC filings

Form D private placements

$6M disclosed across 1 round · 2022

▶$6MraisedDec 2022 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William EngelsExecutive Officer
  • Seth HarrisonDirector
  • Paul Da Silva JardineExecutive Officer, Director
  • Rajesh ChopraExecutive Officer, Director
Offering amount
$30M
Amount sold
$6M
First sale
Dec 2022
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Aethon Therapeutics raised?
Aethon Therapeutics has disclosed $6M raised across 1 round.
Where is Aethon Therapeutics headquartered?
Aethon Therapeutics is headquartered in New York, US.